Singapore, May 8, 2008: Quintiles Transnational Corp., a provider of broad range of professional services has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business. The transaction is contingent upon the completion of certain conditions of the purchase agreement.

 

The acquisition of Eidetics will strengthen Quintiles' core consulting offerings in the areas of product development, commercialization and market access. Quintiles is expanding its consulting practices to help its pharmaceutical, biotech and medical device clients navigate the complex business environment.

 

"The addition of Eidetics to our Quintiles Consulting business will further strengthen our ability to provide our clients with distinctive, data-driven, strategic solutions to their toughest challenges throughout the product lifecycle," said Mr Jay Norman, President, Quintiles Consulting.

 

Eidetics has provided research-based market insights and data analytics to support business decision making in drug development and commercialization for the past 20 years and counts among its repeat clients 18 of the top 20 pharmaceutical companies.

 

Mr Jim Kirk, Partner, Eidetics said, "We believe that joining Quintiles Consulting will build upon the past success of Eidetics' business, while providing our clients enhanced clinical, patient and provider data, greater therapeutic depth and access to global resources."